Changes in the microbiome architecture and bile acids, improved insulin sensitivity and restored β-cell mass and function mediated by incretins, including the glucagon like peptide (GLP1), collectively account for instances of T2D remission after bariatric surgery6. The gene discussed is INS; the disease is type 2 diabetes mellitus.